Skip to content
Screener

Verrica Pharmaceuticals Inc. VRCA Q1 2025 earnings

Reported May 13, 2025 · After market close

Revenue$3.4MMiss by $93.7K
EPS-$1.00Beat by $0.40
Revenue estimate$3.5M
EPS estimate-$1.40

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$0.58

FAQ

When did Verrica Pharmaceuticals Inc. report Q1 2025 earnings?
Verrica Pharmaceuticals Inc. (VRCA) reported Q1 2025 earnings on May 13, 2025 after market close.
What were Verrica Pharmaceuticals Inc.'s Q1 2025 revenue and EPS?
Verrica Pharmaceuticals Inc. reported revenue of $3.4M and eps of $-1.00 for Q1 2025.
Did Verrica Pharmaceuticals Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $3.5M by $93.7K. EPS beat the consensus estimate of $-1.40 by $0.40.
How did Verrica Pharmaceuticals Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 10.1% from $3.8M a year earlier and eps declined 163.2% from $-0.38.
Where can I find Verrica Pharmaceuticals Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-118839) and the 10-Q periodic report (0000950170-25-070452) directly on SEC EDGAR. The filing index links above go to sec.gov.